Endlyz

Developer of small-molecule therapeutics targeting lysosomal dysfunction in neurodegenerative diseases

placeLondon, England, United Kingdom calendar_todayFounded 2021 language endlyz.com

Social engagement

Social engagement: 1.7K social following, 1 post in the last 12 months — below the industry typical range.

Coming soon